Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Uniphos Enterprises's Debt-to-EBITDA or its related term are showing as below:
NSE:UNIENTER's Debt-to-EBITDA is not ranked *
in the Chemicals industry.
Industry Median: 2.005 * Ranked among companies with meaningful Debt-to-EBITDA only.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Uniphos Enterprises Debt-to-EBITDA Related Terms
Uniphos Enterprises Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Uniphos Enterprises's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Uniphos Enterprises's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uniphos Enterprises Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Uniphos Enterprises's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Uniphos Enterprises's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Uniphos Enterprises (NSE:UNIENTER) has a Debt-to-EBITDA of 0.00 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Uniphos Enterprises. According to the industry distribution chart, Uniphos Enterprises ranks #999999 out of 1264 companies in the Chemicals industry.
Is Uniphos Enterprises' Debt-to-EBITDA too high?
Uniphos Enterprises' current Debt-to-EBITDA is 0.00. Based on the distribution chart, Uniphos Enterprises ranks #999999 out of 1264 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Uniphos Enterprises has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphos Enterprises' Debt-to-EBITDA compare to DOW?
According to the Chemicals industry distribution chart, Uniphos Enterprises ranks #999999 out of 1264 companies for Debt-to-EBITDA. This places Uniphos Enterprises in the lower half of its industry. The industry median Debt-to-EBITDA is 2.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.01, based on 1,264 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Uniphos Enterprises. For the Chemicals industry, the median Debt-to-EBITDA is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Uniphos Enterprises's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphos Enterprises stock overvalued right now?
Based on GuruFocus' analysis, Uniphos Enterprises (NSE:UNIENTER) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹61.41, compared to a current price of ₹94.06 — trading 53.2% above its estimated fair value. The current Debt-to-EBITDA is 0.00. Uniphos Enterprises' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Uniphos Enterprises (NSE:UNIENTER), the current Debt-to-EBITDA is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Uniphos Enterprises (NSE:UNIENTER) Overvalued in 2026?
Based on GuruFocus' analysis, Uniphos Enterprises stock appears to be overvalued.
The current stock price of ₹94.06 is trading 53.2% above its estimated GF Value™ of ₹61.41.
GuruFocus considers Uniphos Enterprises to be Significantly Overvalued.
Key valuation signals for NSE:UNIENTER:
Debt-to-EBITDA: 0.00
GF Value™: ₹61.41 vs. price of ₹94.06 (53.2% above fair value)
No single metric tells the full story. See the NSE:UNIENTER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Uniphos Enterprises Ltd is an Indian-based trading company that trades chemicals and other products. The company principally operates through its subsidiaries and is also looking for new opportunities for trading in chemicals in India and abroad. The company operates in a single segment which is trading Geographically, it operates only in India.
68GF Score
Get the complete analysis for NSE:UNIENTER
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNIENTER has been successfully added to your 
